Lyra Therapeutics appoints Jason Cavalier as CFO
Mr. Cavalier joins Lyra after serving as Managing Director, Head of Life Sciences Mergers and Acquisitions at Cantor Fitzgerald, where he led transactions across the medical technology, diagnostics and biopharma sectors.
Prior to Cantor, Mr. Cavalier held several senior-level positions at RBC Capital Markets, including Director, Mergers and Acquisitions.
He also held investment banking roles of increasing responsibility at Barclays Capital, Bear Stearns, and Lehman Brothers. ■